Chelsea, MA – Catalent, a firm specializing in supporting pharmaceutical, biotech, and consumer health partners, recently completed an upgrade at its Chelsea facility, a Center of Excellence for spray dry dispersion and Dry Powder Inhaler (DPI) capsule manufacturing and packaging. The renovation project focused on enhancing potent compounding spaces to support isolated production, meeting the highest industry standards for pharmaceutical manufacturing.
The project was made possible through close collaboration between Fitzemeyer & Tocci Associates, Inc., who provided MEP/FP/FA engineering, and AEC partners SGA & Dream Collaborative, architect; Timberline Construction, construction manager; and the Cumming Group, owner’s project manager. Together, the team delivered a range of upgrades, including airlocks with integrated air showers to prevent contamination between production suites, cGMP-compliant spaces, quality control laboratories, and a packaging line designed for safety and productivity.
Given the precise environmental requirements for pharmaceutical production, Fitzemeyer & Tocci designed a state-of-the-art HVAC system to meet strict temperature and humidity specifications. According to Fitzemeyer & Tocci representatives, these environmental controls were essential to ensuring product quality and operational efficiency throughout manufacturing.
One of the most challenging aspects of the project was performing construction within an occupied, fully operational building. The AEC team worked closely with Catalent to plan construction phases carefully in order to minimize downtime and ensure that operations continued without interruption.
Representatives of Fitzemeyer & Tocci say this project shows the power of collaborative design and engineering within the pharmaceutical sector, and that the enhancements made to the Chelsea facility positions it to meet current and future demands, ensuring continued innovation and high-quality production to support patients worldwide.
